Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+67.2%
5Y CAGR+36.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+67.2%/yr
vs -22.3%/yr prior
5Y CAGR
+36.9%/yr
Recent acceleration
Acceleration
+89.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $168.16M | +3.0% |
| 2024 | $163.29M | +355.8% |
| 2023 | $35.82M | -0.4% |
| 2022 | $35.98M | -3.4% |
| 2021 | $37.25M | +6.4% |
| 2020 | $34.99M | -3.7% |
| 2019 | $36.34M | -63.2% |
| 2018 | $98.71M | +20.4% |
| 2017 | $82.00M | +47.7% |
| 2016 | $55.52M | - |